On Tuesday, Veracyte, Inc VCYT reported second-quarter sales of $114.43 million, up 27$100.3 million.Testing revenue was $107.0 million, an increase of 31%, driven by the strong performance of our Decipher Prostate and Afirma tests.Total test volume grew to 39,023, an increase of 23% compared to the second quarter of 2023.During the quarter, the company achieved a record Decipher Prostate test volume of close to 19,900 tests, driven by recently updated NCCN prostat ...